Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes
Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes
About this item
Full title
Author / Creator
Estrella, Martínez-López Yoscelina , Daniel, Neri-Rosario , Armando, Esquivel-Hernández Diego , Cristian, Padron-Manrique , Aarón, Vázquez-Jiménez , Paul, Sánchez-Castañeda Jean , David, Girón-Villalobos , Cristian, Mendoza-Ortíz , de Lourdes, Reyes-Escogido María , Lola, Evia-Viscarra Maria , Alberto, Aguilar-Garcia , Osbaldo, Resendis-Antonio and Rodolfo, Guardado-Mendoza
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Lifestyle modifications, metformin, and linagliptin reduce the incidence of type 2 diabetes (T2D) in people with prediabetes. The gut microbiota (GM) may enhance such interventions' efficacy. We determined the effect of linagliptin/metformin (LM) vs metformin (M) on GM composition and its relationship to insulin sensitivity (IS) and pancreatic β-ce...
Alternative Titles
Full title
Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes
Authors, Artists and Contributors
Author / Creator
Daniel, Neri-Rosario
Armando, Esquivel-Hernández Diego
Cristian, Padron-Manrique
Aarón, Vázquez-Jiménez
Paul, Sánchez-Castañeda Jean
David, Girón-Villalobos
Cristian, Mendoza-Ortíz
de Lourdes, Reyes-Escogido María
Lola, Evia-Viscarra Maria
Alberto, Aguilar-Garcia
Osbaldo, Resendis-Antonio
Rodolfo, Guardado-Mendoza
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_83b543c854a3489c97c62ff5683e4a7e
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_83b543c854a3489c97c62ff5683e4a7e
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-60081-y
